Intrinsic Value of S&P & Nasdaq Contact Us

Avinger, Inc. AVGR NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
17/100
0/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Avinger, Inc. (AVGR) .

Criteria proven by this page:

  • VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.

Overall SharesGrow Score: 16/100 with 0/7 criteria passed.

SharesGrow 7-Criteria Score
17/100
SG Score
View full scorecard →
VALUE
N/A
No coverage
~
FUTURE
40/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
MOAT
20/100
→ Income
GROWTH
30/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — AVGR

Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.05
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-23.31
Book Value / Share$0.00
Revenue / Share$9.74
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2014 $-389,805.00 $11.21M $-31.96M -285.1%
2015 $-450,895.00 $10.71M $-47.34M -441.9%
2016 $-283,475.00 $19.21M $-56.13M -292.1%
2017 $-175,928.00 $9.93M $-48.73M -490.6%
2018 $-7,736.66 $7.92M $-27.56M -348.2%
2019 $-818.60 $9.13M $-19.75M -216.3%
2020 $-120.80 $8.76M $-19.82M -226.3%
2021 $-65.79 $10.13M $-20.71M -204.4%
2022 $-41.83 $8.27M $-17.43M -210.6%
2023 $-23.31 $7.65M $-18.32M -239.4%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message